Scientists test first pill to stop flu virus in its tracks
NCT ID NCT05202379
Summary
This early-stage study tested a new oral medication called CC-42344, designed to stop Influenza A virus from multiplying in the body. Researchers gave the drug to 80 healthy volunteers to check if it was safe and to measure how the body processes it. The study focused on finding the right dose and understanding side effects before testing in people with actual flu infections.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFLUENZA A are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Linear Clinical Research
Nedlands, Western Australia, 6009, Australia
Conditions
Explore the condition pages connected to this study.